Project profile — Canada's HIV/AIDS Program in Tanzania

This project supports the implementation of Tanzania's National Multi-sectoral Strategic Framework for HIV/AIDS. The Framework encompasses a wide variety of activities in prevention, care, treatment, and impact mitigation of HIV/AIDS. Canada's support through this project enables the Government of Tanzania to expand the level and scope of its expenditures on HIV/AIDS throughout all ministries, departments and agencies and all levels of government, with the majority of funding being provided for activities at the district level. CIDA is working in close collaboration with other donors and the Government of Tanzania to strengthen the effectiveness of its aid through: focusing on effective, transparent, and accountable country systems; increasing coordination and harmonization among donors; and reinforcing mutual accountability. This project fosters greater policy dialogue between CIDA, the Government of Tanzania, and partners, which helps to reinforce efforts for effective, focused aid and long-term development results. Continuous monitoring and evaluation of this project is undertaken in coordination with other donors. The results expected from this project include not only nation-wide progress in addressing HIV/AIDS, but also improvements in the Government of Tanzania's capacity to manage and administer these services, particularly in the areas of transparency, financial management, and accountability. These build on results achieved from CIDA's previous support to Canada's HIV/AIDS Program in Tanzania, which include 55% of mothers receiving antiretroviral (ARV) combination treatment to prevent mother-to-child transmission of HIV in 2008 compared to 34% in 2007.

N/A

Results achieved as of the end of the project (May 2008) include: an increase in the percentage of youth 15–24 who used a condom at first sexual experience from 17% (women) and 26% (men) to 24% and 29% respectively; detection of HIV status among young people improved between 2003–2004 and 2007–2008 from a percentage of 5.9% to 15.2% for males aged 15–24 and from 5.3% to 15.2% for women aged 15–24; and 36% of adults and children with advanced HIV infection received Anti-Retroviral Therapy (ART) in 2008. These efforts will contribute to reducing the prevalence of HIV among young people between the ages of 15 and 24 years and increasing the proportion of people with advanced HIV infection receiving ART.